Nova Eye Medical H1 2022 Results Presentation

Nova Eye Medical's H1 FY2022 results presentation outlines progress across two business units: Glaucoma surgical devices leveraging proprietary iTrack™ microcatheter technology with established USA, German, and Australian sales infrastructure; and 2RT® for intermediate age-related macular degeneration, advancing toward FDA clearance with CE Mark approval in multiple regions.